Articles producció científica> Enginyeria Electrònica, Elèctrica i Automàtica

Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese

  • Dades identificatives

    Identificador: imarina:9287705
    Autors:
    Canyelles, MarinaPerez, AntonioJunza, AlexandraMinambres, InkaYanes, OscarSarda, HelenaRotllan, NoemiJulve, JosepLuis Sanchez-Quesada, JoseTondo, MireiaEscola-Gil, Joan CarlesBlanco-Vaca, Francisco
    Resum:
    High circulating concentrations of the gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) are significantly associated with the risk of obesity and type 2 diabetes (T2D). We aimed at evaluating the impact of glycemic control and bariatric surgery on circulating concentrations of TMAO and its microbiota-dependent intermediate, gamma-butyrobetaine (gamma BB), in newly diagnosed T2D patients and morbidly obese subjects following a within-subject design. Based on HbA1c concentrations, T2D patients achieved glycemic control. However, the plasma TMAO and gamma BB concentrations were significantly increased, without changes in estimated glomerular filtration rate. Bariatric surgery was very effective in reducing weight in obese subjects. Nevertheless, the surgery reduced plasma gamma BB concentrations without affecting TMAO concentrations and the estimated glomerular filtration rate. Considering these results, an additional experiment was carried out in male C57BL/6J mice fed a Western-type diet for twelve weeks. Neither diet-induced obesity nor insulin resistance were associated with circulating TMAO and gamma BB concentrations in these genetically defined mice strains. Our findings do not support that glycemic control or bariatric surgery improve the circulating concentrations of TMAO in newly diagnosed T2D and morbidly obese patients.
  • Altres:

    Autor segons l'article: Canyelles, Marina; Perez, Antonio; Junza, Alexandra; Minambres, Inka; Yanes, Oscar; Sarda, Helena; Rotllan, Noemi; Julve, Josep; Luis Sanchez-Quesada, Jose; Tondo, Mireia; Escola-Gil, Joan Carles; Blanco-Vaca, Francisco
    Departament: Enginyeria Electrònica, Elèctrica i Automàtica
    Autor/s de la URV: Junza Martínez, Alexandra / Yanes Torrado, Óscar
    Paraules clau: Γ-butyrobetaine Type 2 diabetes Trimethylamine-n-oxide Trimethylamine n-oxide Risk Obesity Mortality Microbial-metabolism Liquid chromatography–mass spectrometry Liquid chromatography-mass spectrometry Glycemic control Gamma-butyrobetaine Choline Carnitine Butyrobetaine
    Resum: High circulating concentrations of the gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) are significantly associated with the risk of obesity and type 2 diabetes (T2D). We aimed at evaluating the impact of glycemic control and bariatric surgery on circulating concentrations of TMAO and its microbiota-dependent intermediate, gamma-butyrobetaine (gamma BB), in newly diagnosed T2D patients and morbidly obese subjects following a within-subject design. Based on HbA1c concentrations, T2D patients achieved glycemic control. However, the plasma TMAO and gamma BB concentrations were significantly increased, without changes in estimated glomerular filtration rate. Bariatric surgery was very effective in reducing weight in obese subjects. Nevertheless, the surgery reduced plasma gamma BB concentrations without affecting TMAO concentrations and the estimated glomerular filtration rate. Considering these results, an additional experiment was carried out in male C57BL/6J mice fed a Western-type diet for twelve weeks. Neither diet-induced obesity nor insulin resistance were associated with circulating TMAO and gamma BB concentrations in these genetically defined mice strains. Our findings do not support that glycemic control or bariatric surgery improve the circulating concentrations of TMAO in newly diagnosed T2D and morbidly obese patients.
    Àrees temàtiques: Medicine, general & internal Internal medicine Clinical biochemistry
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: oscar.yanes@urv.cat alexandra.junza@urv.cat
    Identificador de l'autor: 0000-0003-3695-7157 0000-0001-7205-0419
    Data d'alta del registre: 2024-10-12
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    Enllaç font original: https://www.mdpi.com/2075-4418/12/11/2783
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Diagnostics. 12 (11): 2783-
    Referència de l'ítem segons les normes APA: Canyelles, Marina; Perez, Antonio; Junza, Alexandra; Minambres, Inka; Yanes, Oscar; Sarda, Helena; Rotllan, Noemi; Julve, Josep; Luis Sanchez-Quesada, (2022). Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese. Diagnostics, 12(11), 2783-. DOI: 10.3390/diagnostics12112783
    DOI de l'article: 10.3390/diagnostics12112783
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2022
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Clinical Biochemistry,Medicine, General & Internal
    Γ-butyrobetaine
    Type 2 diabetes
    Trimethylamine-n-oxide
    Trimethylamine n-oxide
    Risk
    Obesity
    Mortality
    Microbial-metabolism
    Liquid chromatography–mass spectrometry
    Liquid chromatography-mass spectrometry
    Glycemic control
    Gamma-butyrobetaine
    Choline
    Carnitine
    Butyrobetaine
    Medicine, general & internal
    Internal medicine
    Clinical biochemistry
  • Documents:

  • Cerca a google

    Search to google scholar